How big is the Acute Myeloid Leukemia Market?

The Acute Myeloid Leukemia Market size is expected to reach USD 1.83 billion in 2024 and grow at a CAGR of 10.15% to reach USD 2.97 billion by 2029. Read More

What is the current Acute Myeloid Leukemia Market size?

In 2024, the Acute Myeloid Leukemia Market size is expected to reach USD 1.83 billion. Read More

Who are the key players in Acute Myeloid Leukemia Market?

Pfizer Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Otsuka holdings co., ltd. and Bristol Myers Squibb are the major companies operating in the Acute Myeloid Leukemia Market. Read More

Which is the fastest growing region in Acute Myeloid Leukemia Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Acute Myeloid Leukemia Market?

In 2024, the North America accounts for the largest market share in Acute Myeloid Leukemia Market. Read More

What years does this Acute Myeloid Leukemia Market cover, and what was the market size in 2023?

In 2023, the Acute Myeloid Leukemia Market size was estimated at USD 1.66 billion. The report covers the Acute Myeloid Leukemia Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Acute Myeloid Leukemia Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Acute Myeloid Leukemia Market Share

Statistics for the 2023 & 2024 Acute Myeloid Leukemia market share, created by Mordor Intelligence™ Industry Reports. Acute Myeloid Leukemia share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Acute Myeloid Leukemia Industry

The acute myeloid leukemia market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Novartis AG, Teva Pharmaceuticals, Pfizer, Bristol Myer Squibb, and Sanofi-Aventis (Genzyme Corporation), among others.